Covestro officials are boasting how their Apec 1745 high heat polycarbonate was the material of choice for Gerresheimer AG’s new tamper-evident luer lock closure for syringes. In the growing prefilled syringes market, the adapter for screwing in the needle and the syringe cap plays a key role when it comes to ensuring ease of use and reliable dosage, […]
gerresheimer
Gerresheimer revenues up 6.7% in Q3
Gerresheimer AG’s revenue grew 6.7% year-over-year during its third quarter — with adjusted earnings up 2% — as medical plastic systems continued to be a revenue growth driver, especially due to the company’s U.S. inhaler project. “Our business is pulling ahead as expected: The third quarter went well. We are consequently confirming our revenue guidance for this […]
Gerresheimer’s Sensile Medical wins CE Mark for infusion pump
Gerresheimer subsidiary Sensile Medical said today it won CE Mark approval in the European Union for its wearable micropump intended for use in the treatment of Parkinson’s disease. The newly cleared device features automatic filling for use with liquid medicines, and includes a color display, charging unit and leather bag which allows the device to be worn […]
Gerresheimer to acquire Sensile Medical and its drug-delivery tech
Updated 7/13 to include the deal’s financial details. Gerresheimer plans to acquire Swiss medical technology company Sensile Medical and its array of liquid drug delivery devices. The buyout is a perfect fit in Gerresheimer’s portfolio, the company explained, since it will boost Gerresheimer’s drug delivery offerings and add new digital and electronic capabilities into the mix. […]
Gerresheimer launches new syringe safety solutions
Gerresheimer announced that it has acquired an exclusive license from West Pharmaceutical Services to complete its prefillable syringes portfolio with passive syringe safety solutions. “As a result of our long-standing partnership with the leading manufacturer of packaging components and delivery devices for parenteral drugs, we are pleased to have acquired the rights to market this […]
